Showing results (691-700 of 1,823) with videos related to
Sort By:
Pageof 183
Journal of Interventional Cardiology|July 22, 2021
Reduction of Lipid-Core Burden Index in Nonculprit Lesions at Follow-Up after ST-Elevation Myocardial Infarction: A Randomized Study of Bioresorbable Vascular Scaffold versus Optimal Medical TherapyJoelle Kefer, Patrick Chenu, Olivier Gurné, et al.Journal of Interventional Cardiology|December 31, 2020
Impact of Combined "CHADS-BLED" Score to Predict Short-Term Outcomes in Transfemoral and Transapical Aortic Valve ReplacementVerena Veulemans, Oliver Maier, Georg Bosbach, et al.Journal of Interventional Cardiology|December 30, 2020
Feasibility of Left Atrial Appendage Closure in Atrial Fibrillation Patients with a History of Intracranial Bleeding: A Systematic Review of Observational StudiesMuhammad Ajmal, Qurat Ul Ain Riaz Sipra, Cristina Pecci, et al.Journal of Interventional Cardiology|April 17, 2013
Long-term clinical follow-up after drug-eluting stent implantation for bare metal in-stent restenosisBalazs Berta, Zoltan Ruzsa, Gyorgy Barczi, et al.Journal of Interventional Cardiology|May 9, 2012
Devices to treat peripheral chronic total occlusionsHazim Al-Ameri, Leonardo Clavijo, Ray V Matthews, et al.Journal of Interventional Cardiology|March 14, 2013
Long-term clinical outcomes of the one-stent technique versus the two-stent technique for non-left main true coronary bifurcation disease in the era of drug-eluting stentsYoon-Seok Koh, Pum-Joon Kim, Kiyuk Chang, et al.Journal of Interventional Cardiology|March 16, 2013
Outcomes of overlapping heterogeneous drug-eluting stents versus homogeneous drug-eluting stents for diffuse lesions in small coronary arteriesSheng Wen Liu, Shu Bin Qiao, Bo Xu, et al.Journal of Interventional Cardiology|January 22, 2013
Racial disparities in left main stenting: insights from a real world inner city populationTamam Mohamad, Sidakpal S Panaich, Anas Alani, et al.Journal of Interventional Cardiology|February 1, 2013
Everolimus-eluting stents versus sirolimus- or paclitaxel-eluting stents: two-year results from the Guthrie Health Off-Label Stent (GHOST) registryKishore J Harjai, Sreekanth Kondareddy, Brian Pinkosky, et al.Journal of Interventional Cardiology|February 5, 2013
Rationale and design of the on-treatment PLAtelet Reactivity-Guided Therapy Modification FOR ST-Segment Elevation Myocardial Infarction (PLATFORM) randomized trialIgor Mrdovic, Lidija Savic, Gordana Krljanac, et al.Pageof 183